Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 12/20 | 0.63 |
| ▸ | MAOA | P21397 | 1/20 | 0.53 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.52 |
| ▸ | PTPRB | P23467 | 1/20 | 0.52 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.52 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.52 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.52 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.51 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18164441 | 0.86 | MAOB (0.57) | MAOBMAOAPTPN2PTPN1PTPRB | |
| SCHEMBL15833208 | 0.85 | MAOB (0.72) | MAOBMAOAPTPN2PTPN1PTPRB | |
| SCHEMBL13462743 | 0.85 | MRGPRX4 (0.54) | MAOBPTPN2PTPN1PTPRBPTPN6 | |
| SCHEMBL5512060 | 0.85 | MAOB (0.63) | MAOBMAOAPTPN2PTPN1PTPRB | |
| SCHEMBL5512565 | 0.85 | MAOB (0.59) | MAOBMAOAPTPN2PTPN1PTPRB | |
| SCHEMBL19679864 | 0.84 | MAOB (0.59) | MAOBMAOAPTPN2PTPN1PTPRB | |
| SCHEMBL10335673 | 0.84 | MAOB (0.65) | MAOBMAOAPTPN2PTPN1PTPRB | |
| SCHEMBL791923 | 0.83 | MAOB (0.69) | MAOBMAOAPTPN2PTPN1PTPRB | |
| SCHEMBL18003540 | 0.82 | MAOB (0.60) | MAOBMAOAPTPN2PTPN1PTPRB | |
| SCHEMBL18002939 | 0.82 | CYP4F2 (0.70) | MAOBMAOAPTPN2PTPN1PTPRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170348258-A1 | 3-Amino Benzamide Derivative Serving As B-Lactam Auxiliary Antibiotic, Preparation Method and Use Thereof | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2017-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170348258-A1 | 3-Amino Benzamide Derivative Serving As B-Lactam Auxiliary Antibiotic, Preparation Method and Use Thereof | BCAT2, SBDS, BCAT1 | MAOB 110/4885MAOA 528/4885PTPN2 4201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.